Palliative portal vein stent placement for lymphatic recurrence of gastric cancer.
BACKGROUND
Percutaneous transhepatic stenting of the main portal vein is a rare intervention.


METHODS
In the current patient, percutaneous angioplasty and stenting of a main portal vein stenosis due to lymphatic recurrence of gastric cancer ameliorated the progressing therapeutic restriction. The wall stent achieved portal venous patency that enabled ongoing chemotherapy. The stent remained patent for the entire subsequent survival period.
Heyne
J-P
JP
Institute of Diagnostic and Interventional Radiology, Friedrich-Schiller-University Jena, Erlanger Allee 101, 07740 Jena, Germany. jens-peter.heyne@med.uni-jena.de
Pfleiderer
S O R
SO
Trebing
G
G
Scheele
J
J
Kaiser
W A
WA
D000328:Adult; D017130:Angioplasty / Q000379:methods*; D018279:Carcinoma, Signet Ring Cell / Q000150:complications* / Q000473:pathology* / Q000601:surgery; D003251:Constriction, Pathologic / Q000209:etiology / Q000601:surgery; D005260:Female; D005743:Gastrectomy; D006801:Humans; D008207:Lymphatic Metastasis / Q000473:pathology*; D010166:Palliative Care; D011169:Portal Vein / Q000473:pathology* / Q000601:surgery*; D015607:Stents; D013274:Stomach Neoplasms / Q000150:complications* / Q000473:pathology* / Q000601:surgery